Evidence of founder mutations in Finnish BRCA... [Am J Hum Genet. 1998] - PubMed

Save items

loading

Related citations in PubMed

Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. [Hum Mol Genet. 1997]
Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
Vehmanen P, Friedman LS, Eerola H, McClure M, Ward B, Sarantaus L, Kainu T, Syrjäkoski K, Pyrhönen S, Kallioniemi OP, et al. Hum Mol Genet. 1997 Dec; 6(13):2309-15.
Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland. [Eur J Hum Genet. 2000]
Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.
Sarantaus L, Huusko P, Eerola H, Launonen V, Vehmanen P, Rapakko K, Gillanders E, Syrjäkoski K, Kainu T, Vahteristo P, et al. Eur J Hum Genet. 2000 Oct; 8(10):757-63.
BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients. [Eur J Hum Genet. 2001]
BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients.
Sarantaus L, Vahteristo P, Bloom E, Tamminen A, Unkila-Kallio L, Butzow R, Nevanlinna H. Eur J Hum Genet. 2001 Jun; 9(6):424-30.
Review Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. [Nat Med. 1996]
Review Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families.
Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin AK, Daly M, Wagner-Costalos J, Berman D, et al. Nat Med. 1996 Nov; 2(11):1179-83.
Review From bench to bedside... but when? [Genome Res. 1997]
Review From bench to bedside... but when?
Eng C. Genome Res. 1997 Jul; 7(7):669-72.

See reviews... See all...

Cited by 13 PubMed Central articles

Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control. [EPMA J. 2010]
Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.
Janavičius R. EPMA J. 2010 Sep; 1(3):397-412. Epub 2010 Jun 27.
Review Pathology of hereditary breast cancer. [Cell Oncol (Dordr). 2011]
Review Pathology of hereditary breast cancer.
van der Groep P, van der Wall E, van Diest PJ. Cell Oncol (Dordr). 2011 Apr; 34(2):71-88. Epub 2011 Feb 19.
Mutation analysis of the AATF gene in breast cancer families. [BMC Cancer. 2009]
Mutation analysis of the AATF gene in breast cancer families.
Haanpää M, Reiman M, Nikkilä J, Erkko H, Pylkäs K, Winqvist R. BMC Cancer. 2009 Dec 21; 9:457. Epub 2009 Dec 21.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Evidence of founder mutations in Finnish BRCA1 and BRCA2 families.
Evidence of founder mutations in Finnish BRCA1 and BRCA2 families.
Am J Hum Genet. 1998 Jun ;62(6):1544-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Evidence of founder mutations in Finnish BRCA1 and BRCA2 families.

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 13 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information